Bwxt Itg Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BWXT ITG, and what generic and branded alternatives to BWXT ITG drugs are available?
BWXT ITG has one approved drug.
Summary for Bwxt Itg
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Bwxt Itg
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bwxt Itg | INDIUM IN 111 OXYQUINOLINE | indium in-111 oxyquinoline | INJECTABLE;INJECTION | 202586-001 | Jul 25, 2018 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
